PHARMABOLD 500

Description

Chemical name: (17β)-3-Oxoandrosta-1,4-dien-17-yl undec-10-enoate Formula: C30H44O3 Anabolic activity index: 100% Androgenic activity index: 50% PHARMABOLD 500 – PHARMACOM LABS 1 VIAL X 10 ML X 500 MG/ML Our enhanced version of PHARMABOLD 300 represents a significant advancement, utilizing high-percentage drug synthesis technologies to create a nearly double-concentrated formula compared to the original PHARMABOLD 300. This modification aims to provide athletes with a more potent and efficient option for achieving their fitness goals. History and Development: Modified Formulation: A refined iteration of PHARMABOLD 300, achieved through advanced drug synthesis technologies. Origins of Boldenone: Developed as a prolonged version of methandienone and patented by Ciba in 1949 as a synthetic anabolic steroid. Original Purpose: Initially intended for treating dystrophy and increasing bone weight and density in osteoporosis. Benefits: High Concentration: Almost double the concentration compared to PHARMABOLD 300. Strong Anabolic Properties: Exhibits robust anabolic and moderate androgenic characteristics. Low Androgenic Impact for Women: Suitable for female use with a low risk of virilization. Stimulation of Hematopoiesis: Promotes increased red blood cell production, enhancing oxygen delivery to muscles. Muscle Growth: Induces slow but substantial lean muscle growth, especially noticeable in long cycles (12 weeks or more). Muscle Density: Muscles developed on a boldenone cycle are denser compared to those on testosterone. Appetite and Power Increase: Significantly raises appetite and enhances power rate. Warning and Dosage Instructions: High Concentration Usage: For first-time use of a high-concentrated drug, inject only ½ ml initially to monitor body reactions and prevent potential side effects. Possible Side Effects: Side effects may include post-injection pain (PIP), elevated body temperature, and lumps. Mitigation Strategies: Learn how to mitigate post-injection pain HERE.